VANFLYTA® Commercialization Agreement Expands Access to AML Treatment in China
Innovent Biologics and Daiichi Sankyo enter an exclusive agreement to commercialize VANFLYTA®…
Lacutamab Advances Toward Phase 3 Trial in T-Cell Lymphoma
Sobi and Innate Pharma partner to advance lacutamab into a Phase 3…
Biotech Collaboration Aims to Advance Personalized Brain Cancer Therapy in Saudi Arabia
Northwest Biotherapeutics and SPIMACO have signed an MoU to explore the approval,…
Advanced Onco-Surgery Services Expand Access to Comprehensive Cancer Care
Canadian Specialist Hospital Dubai expands its oncology services with dedicated onco-surgery specialists,…
Boehringer Ingelheim launches three phase III trials in precision Oncology
Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…
Burjeel Cancer Institute Honors 15 Cancer Survivors at ‘Circle of Hope’ Event
Burjeel Cancer Institute honored 15 cancer survivors during its ‘Circle of Hope’…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
LCRF and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment
The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, has announced…
IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
IBA has entered into a sponsored research agreement with The University of…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
